Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.

Abstract

Four patients with recurrent, symptomatic ventricular tachycardia (VT) refractory to conventional antiarrhythmic agents were given flecainide acetate to control arrhythmias. Ventricular stimulation studies were performed in all patients before and 1 to 2 weeks after initiation of oral flecainide therapy. Before flecainide, all patients had easily inducible… (More)

Topics

Cite this paper

@article{Oetgen1983ClinicalAE, title={Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.}, author={William J. Oetgen and Paul Tibbits and Maryline Abt and Rick Goldstein}, journal={The American journal of cardiology}, year={1983}, volume={52 7}, pages={746-50} }